ProShares UltraShort Nasdaq Biotechnology (BIS)
NASDAQ: BIS · IEX Real-Time Price · USD
18.07
+0.31 (1.75%)
Dec 29, 2023, 4:00 PM EST - Market closed
1.75% (1D)
| Assets | $3.67M |
| Expense Ratio | 0.95% |
| PE Ratio | n/a |
| Shares Out | n/a |
| Dividend (ttm) | $0.32 |
| Dividend Yield | 1.75% |
| Ex-Dividend Date | Dec 20, 2023 |
| Payout Ratio | n/a |
| 1-Year Return | -8.41% |
| Volume | 1,382 |
| Open | 17.92 |
| Previous Close | 17.76 |
| Day's Range | 17.92 - 18.09 |
| 52-Week Low | 17.48 |
| 52-Week High | 26.51 |
| Beta | n/a |
| Holdings | 7 |
| Inception Date | Apr 8, 2010 |
About BIS
Fund Home PageThe ProShares UltraShort Nasdaq Biotechnology (BIS) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. BIS was launched on Apr 8, 2010 and is issued by ProShares.
Asset Class Equity
Category Trading--Inverse Equity
Stock Exchange NASDAQ
Ticker Symbol BIS
ETF Provider ProShares
Index Tracked NASDAQ / Biotechnology
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 20, 2023 | $0.17591 | Dec 28, 2023 |
| Sep 20, 2023 | $0.11866 | Sep 27, 2023 |
| Jun 21, 2023 | $0.02137 | Jun 28, 2023 |
| Mar 25, 2020 | $0.1033 | Apr 1, 2020 |
| Dec 24, 2019 | $0.1653 | Jan 2, 2020 |
| Sep 25, 2019 | $0.3247 | Oct 2, 2019 |
News
3 ETFs in “Oversold” Territory to Start the Week
Technical analysis can tell investors a lot about both stocks and ETFs, including when some might have been overbought, or even oversold.
1 year ago - ETF Trends
Cap-Weighting Crucial When Indexing Biotech
The biotechnology industry is a bifurcated space. In one corner, you have nascent, small-cap companies that don't yet have steady revenue streams because their new drug or treatment is still in develo...
2 years ago - ETF Trends